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ABSTRACT 
 
Endophytes are endosymbiotic microorganisms that 
act as reservoir of novel bioactive secondary 
metabolites with antimicrobial, cytotoxic and anti-
cancer activities. In the present study, the extracts  
of 26 different endophytic fungal strains were 
screened for their antimicrobial and anti-
inflammatory activities. The results showed a wide 
variety of antimicrobial activities against 12 target 
microorganisms including three Gram (+) bacteria, 
three Gram (-) bacteria, 3 yeasts, 2 dermatophytic 
fungi and one keratinophilic fungus. Four fungal 
extracts (Aspergillus versicolor, A. awamori,                      
A. niger and Penicillium funiculosum) displayed a 
broader antibacterial spectrum and inhibited the 
growth of all Gram (+) and Gram (-) bacterial 
species. The extracts of 8 endophytic fungi inhibited 
the growth of the two tested dermatophytic strains 
(Trichophyton mentagrophytes and T. rubrum). 
Only eight fungal extracts have an inhibition 
activity against the keratinophilic fungal strain 
(Chrysosporium tropicum). The anti-inflammatory 
assay showed that the extracts of Emericella 
nidulans, Pleospora tarda and Penicillium funicu-
losum had good activities in inhibition of protein 
denaturation reached to 83%, 82.5% and 81.4%, 
respectively. Also, Emericella nidulans and Pleo-
spora tarda recorded the maximum inhibition effect 
on bovine serum albumin denaturation reached to 
95% and 90.7%, respectively. On the other side, 
Emericella nidulans showed the maximum 
inhibition activity (69.5%) out of all tested 
endophytic strains against humun red blood cells 
membrane stabilization assay. In conclusion some 
secondary metabolites of endophytic fungi have a 
promising potential as antimicrobial and anti-
inflammatory compounds.  
 
Keywords: Endophytes; Fungi; Antimicrobial; 
Anti-inflammatory; Drug discovery. 
 
1. INTRODUCTION 
 
 World health problems caused by drug 
resistant bacteria and fungi are increasing. Many 
pathogenic microorganisms have developed resi-
stance due to the misusage or long-term usage of the 
same class of antibiotics. Intensive search for more 
effective antibiotics to deal with these problems is 
now ongoing [1]. The isolation of novel secondary 
metabolites from the endophytes is a progressive 
research field [2]. Endophytic microbes are fungi 
and bacteria that colonize internal tissues of living 
plants without causing any adverse effects on                 
its host [3-5]. Endophytes are endosymbiotic 
microorganisms that act as reservoirs of novel 
bioactive secondary metabolites, such as alkaloids, 
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phenolic acids, quinones, steroids, saponins, tannins, 
and terpenoids that are of interest for specific 
medicinal applications [6, 7]. The bioactivity of the 
secondary metabolites of endophytic fungi includes 
antimicrobial, anti- inflammatory, anti-proliferative 
or cytotoxic activity towards human cancer cell 
lines, and activity against plant pathogens [8-10]. 
 The researchers are currently paying more 
attention to the drug development from the 
endophytic fungi [11-15]. The search for new 
antimicrobial compounds is important as bacterial 
and fungal infection remains the main cause for 
morbidity and mortality worldwide due to microbial 
resistance against the present commercially 
antimicrobial drugs [16]. Moreover, due to risk of 
adverse effects encountered with the use of 
synthetic antibiotics, endophytic fungi may offer an 
alternative source for antimicrobial agent with 
significant activity against pathogenic and infective 
microorganisms [17].  
 Inflammation is a normal protective response 
to tissue injury which damaged by microbial agents, 
physical trauma or noxious chemical. Inflammation 
is associated with pain, increase of vascular 
permeability, membrane alteration and protein 
denaturation due to release of lysosomal enzymes, 
kinins, prostroglandins and histamine [18]. The 
lysosomal enzymes released during inflammation 
produced a variety of disorders, so stabilization of 
lysosomal membrane is important in limiting the 
inflammatory response [19]. The search for anti-
inflammatory properties has been on the rise due to 
their potential use in the therapy of various chronic 
and infectious diseases [20]. The prevailing non-
steroidal anti- inflammatory drugs (NSAIDs) in the 
treatment of diseases associated with inflammatory 
reactions has adverse effects which pose a major 
problem in the clinical use. The greatest disad-
vantage in the presently available potent synthetic 
anti-inflammatory drugs lies in their toxicity [21]. 
Moreover, long-term use of NSAIDs can cause 
peptic ulcer [22]. Therefore, it is necessary to 
develop a novel anti-inflammatory agent that             
could overcome the disadvantages of NSAIDs. 
Furthermore, identification of such agent from 
natural origin could confer safety and efficacy for 
the treatment of inflammation [23].   
 For these reasons, in this study, the anti-
bacterial, anti-dermatophytic and anti-keratinophilic 
fungi, anti-yeasts and anti-inflammatory activities of 
the extracts of 26 selected endophytic fungal strains 
were evaluated.    
 
2. MATERIALS AND METHODS 
 
2.1. Endophytic fungi 
 
 Total of 26 endophytic fungal strains were 
kindly provided by the Assiut University Myco-
logical Centre (AUMC), Assiut University, Assiut 
Egypt. The fungal cultures were sub-grown on fresh 
slants have potato dextrose agar medium and 
incubated at 28±20C for 10 days before used. 
 
2.2. Preparation of fungal extract 
 
 Fungal strains grown on 50 ml of potato 
dextrose broth (PDB) in 250 ml Erlenmeyer  flasks. 
Cultures were incubated for 10 days at 28±2ºC. The 
mycelia and the fermentation broth of each fungal 
strain were blended with 150 ml ethanol in electric 
blender; the extracts were filtered using filter paper 
to remove the mycelia. Mislabel extracts were, 
individually, transferred into rotatory evaporator 
under reduced pressure at 35ºC till semisolid residue 
was obtained. 
 
2.3. Determination of antimicrobial activities 
 
2.3.1. Bacterial strains 
 
 Three strains of Gram (+) bacteria namely: 
Bacillus subtilis AUMC B-101, Bacillus cereus 
AUMC B-70 and Staphylococcus aureus AUMC 
6538, in addition to three strains of Gram (-) 
bacteria namely Escherichia coli NCCB  50028, 
Serratia marcescens AUMC B-89 and Klebsiella sp. 
AUMC B-77 were obtained from the cultures 
collection of the AUMC. Bacterial cultures were 
cultivated on nutrient agar (NA) slants and 
incubated at 370C for 24 h before using.  
2.3.2. Dermatophytic and keratinophilic strains 
 
 Two strains of dermatophytic fungi named 
Tricophyton mentagrophytes AUMC 2360 and 
Tricophyton rubrum AUMC 10337 in addition              
to one strain of keratinophilic fungus named 
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Chrysosporium tropicum AUMC 1804 were used         
to determine the anti-dermatophytic and keratino-
philic activities of the fungal extracts. Also, these 
strains were kindly provided by the AUMC and 
cultivated on sabouraud dextrose agar (SDA) 
medium and incubated at 28 ± 20C for 7 days before 
using. 
 
2.3.3. Yeast strains 
 
 Two strains of pathogenic Candida species 
(Candida albicans AUMC 9212 and Candida 
parapsilosis AUMC 9163) in addition to one strain 
of Saccharomyces cerevisiae AUMC 203 were 
obtained from AUMC. Yeast cultures were grown 
on SDA medium and incubated at 30 ± 20C for 48 h 
before used. 
 
2.3.4. Agar well diffusion assay 
 
 The antimicrobial assay was performed by 
agar well diffusion method [24]. A spore suspension 
of each of the different tested bacterial and fungal 
strains was prepared. Petri dishes have NA for 
bacteria and sabouraud dextrose agar for fungi was 
prepared. One ml of spore suspension of each of the 
different bacterial or fungal strain was transferred to 
suitable number of dishes containing the appropriate 
medium. A sterile swab was used to distribute 
bacterial or fungal suspension on the solidified agar 
plates. The plates were allowed to dry for 15 
minutes. Wells were then prepared in the plates with 
the help of a cork-borer (1 cm). A total of 100 µl of 
the test endophytic fungal extract were introduced 
into the well. The plates were incubated overnight  
at 370C for bacterial strains at 300C for 48 h for 
yeast strains and at 280C for 5 days for both 
dermatophytic and keratinophilic strains. Microbial 
growth was determined by measuring the diameter 
of inhibition zone. Ethanol as a negative control    
and chloramphenicol and clotrimazole as posi-            
tive control for antibacterial and antifungal, 
respectively were used. All results were recorded           
as mean values of three replicates ± standard 
deviation.   
 
 
 
2.3.5. Determination of anti-inflammatory 
activities  
 
2.3.5.1. Protein denaturation assay 
 
 The anti-inflammatory activity of the endo-
phytic fungal extracts was tested by the protein 
denaturation method as described by Padmanabhan 
and Jangle [25] with some modification. Briefly, the 
reaction included 10mµl of the fungal extract and    
3 ml of phosphate-buffered saline (pH 6.5) which 
was vortex with 0.5 ml of egg albumin and 
incubated at 25ºC for 15 min. A denaturation 
reaction was induced in a 65ºC water bath for                
12 min. After cooling, absorbance was measured at 
660 nm by spectrophotometer using double distilled 
water as the blank. The percentage inhibition of 
protein denaturation was appraised by the following 
formula:  
Inhibition% = (Ac - As/Ac) × 100    
where Ac and As represent control and sample 
absorbance, respectively.  In this assay, diclofenac 
sodium a powerful NSAID was used as a standard. 
The samples were analyzed in triplicates. 
 
2.3.5.2. Albumin denaturation assay  
 
 According to method of Williams et al. [26] 
and Shah et al. [27], with minor modifications, a 
solution of 0.2% W/V of bovine serum albumin 
(BSA) was dissolved in Tris buffer saline and pH 
was adjusted using to glacial acetic acid to 6.8.                
A total of 2.5 ml of the 0.2% W/V BSA was 
transferred to tube containing 50 μl of fungal extract 
in test tube and 50 μl of standard (diclofenac 
sodium) in standard tubes. The solution was heated 
at 72°C for 5 minutes and then cooled at room 
temperature for 15 minutes. The control was taken 
without the extracts. The absorbance of solution was 
read at 660nm in spectrophotometer against blank 
and the percentage of inhibition was calculated 
using the following formula  
Inhibition% = (Ac - As)/Ac×100  
where: Ac and As represent control and sample 
absorbance, respectively. The samples were analy-
zed in triplicates. 
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2.3.5.3. Membrane stabilization assay 
  
Preparation of human red blood cells (HRBCs) 
suspension 
 The blood was collected from healthy human 
who had not taken any NSAIDs for 2 weeks prior to 
the experiment. The fresh whole human blood (10 
ml) was centrifuged at 3000 rpm for 10 min and 
washed three times with equal volume of normal 
saline. The volume of blood was measured and 
reconstituted as 10% v/v suspension with normal 
saline [28].  
  
Human red blood corpuscles (HRBCs) membrane 
stabilization method 
 Observations and conclusion for anti-
inflammatory activity of fungal extracts were made 
on the basis of stabilization of HRBCs membrane by 
hypotonicity induced membrane lysis as recorded by 
Shing and Kumar [29] and Dhamodaran and 
Rajeswari [30] with minor modification. Assay 
mixture was prepared by mixing 50µl of fungal 
extracts with 1.5 ml phosphate buffer (pH 7.4, 0.15 
M), 1.5 ml hyposaline (0.36%) and 50 µl HRBCs 
suspension (10% v/v). The mixture was incubated in 
water bath at 56ºC for 30 min then cooled under 
running tap water. The samples were centrifuged at 
2500 rpm for 5 min.  Diclofenac sodium was used 
as positive control. The absorbance was measured at 
560 nm in spectrophotometer. Hemolysis produced 
in the presence of distilled water was taken as 
100%. Percentage of HRBCs membrane stabili-
zation/protection was calculated using the following 
formula:  
Stabilization % = (Ac - As)/Ac×100  
where: Ac and As represent control and sample 
absorbance, respectively. The samples were 
analyzed in triplicates. 
 
3. RESULTS AND DISSCUSSION 
 
3.1. Antimicrobial activities  
 
 The crude ethanolic extracts of 26 endophytic 
fungal strains exhibited a wide variety of 
antimicrobial activities against 12 tested organisms: 
3 Gram (+) bacteria (Bacillus subtilis, B. cereus and 
Staphylococcus aureus), 3 Gram (-) bacteria 
(Klebsiella sp., Escherichia coli and Serratia 
marcescens), 3 yeasts, (Candida parapsilosis,              
C. albicans and Saccharomyces cerevisiae) and            
two dermatophyte (Trichophyton mentagrophytes 
and T. rubrum) and one keratinophilic fungus 
(Chrysosporium tropicum) by agar well diffusion 
method.  The results of antibacterial activity assay 
showed that, extracts of 22 endophytic fungi 
(84.6%) produced bioactive compounds that 
exhibited antibacterial activity against at least one 
test bacterium with inhibition zones ranging from 5 
to 45 mm. Four (15.4%) fungal extracts (Aspergillus 
versicolor, A. awamori, A. niger and Penicillium 
funiculosum) displayed a broader antibacterial 
spectrum and inhibited the growth of all positive 
and negative bacterial species (Table 1). This result 
is better than those recorded by other several 
studies. In a preliminary study recorded by Wang et 
al. [31] on screening of some endophytic fungi for 
production of antimicrobial activities found that 
more than 50% of isolates displayed antimicrobial 
activity against at least one tested microorganisms. 
Gong and Guo [32] reported that 56% of endophytic 
fungi inhibited growth of at least one of the test 
organisms and 8% showed broad spectrum inhi-
bition. Crude extracts of 75% of tested endophy-       
tic fungi tested by Kharwar et al. [33] showed 
antibacterial potential against one or more clinical 
human pathogen. Siqueira et al. [34] reported that 
only 16 out of 203 (7.9%) endophytic isolates 
showed antimicrobial activities with a wider action 
spectrum inhibiting Gram (+) and (-) bacteria and 
fungi. Tong et al. [35] found that 66 of 72 (92%) 
endophytic fungal isolates exhibited a significant 
inhibitory activity at least against one test 
microorganism with diameters of inhibition zones 
ranging from 9 to 26 mm for the test bacteria.  
 The Gram (+) bacteria tested in the present 
study appeared to be more susceptible to the 
inhibitory effect of the crude extracts than Gram (-) 
bacteria. This result is in agreement with previous 
study by Chareprasert et al. [36] who found that 
most of the bioactive metabolite compounds from 
endophytic fungi were more effective against Gram 
(+) than Gram (-) bacteria and pathogenic fungi. 
The result in Table 1 showed that the negative 
control did not show any inhibition while antibiotic 
control showed mean zones of inhibition ranging 
from 5 to 45 mm in the agar well diffusion assay. 
Crude extract of Aspergillus terreus exhibited 
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inhibition zone of 10 mm against Staphylococcus 
aureus and 9 mm against each of Escherichia coli 
and Klebsiella pneumonia of 9 tested crude extracts 
of endophytic fungal species against the bacteria 
and fungi by well diffusion method. Moreover, 
endophytic fungi isolated from Salvadora oleoides 
Decne showed potent antimicrobial activity against 
Salmonella typhi, Escherichia coli, Klebsiella pneu-
moniae and Aspergillus niger [38]. Conclusively, 
Bugni and Ireland [39] found that Aspergillus 
genera are a major contributor of antimicrobial 
compound of fungal origin. Ogidi et al. [15] 
returned the antimicrobial activity of Lenzites 
quercina to the presence of fatty acids and other 
phytochemicals. 
 
 
 
Table 1. Antibacterial activities of the ethanolic extracts of 26 endophytic fungi against three different strains of each of 
Gram (+) and Gram (-) bacteria 
 
Fungal strains 
 
Gram negative bacteria Gram positive bacteria 
Klebsiella sp. 
AUMC  
B-77 
E. coli 
NCCB 
50028 
S. marcescens 
AUMC  
B-89 
B. subtilis 
AUMC 
B-101 
B. cereus 
AUMC 
B-70 
S. aureus 
AUMC 
6538 
Alternaria 
A. alternata AUMC  6836 -ve -ve -ve -ve -ve -ve 
A. alternata AUMC 8840 -ve -ve -ve -ve -ve -ve 
A. alternata AUMC8841 -ve -ve -ve -ve -ve -ve 
Aspergillus 
A. awamori AUMC 8855 15 ± 0.09 20 ± 0.07 30 ± 0.1 25 ± 0.3 25 ± 0.1 20 ± 0.2 
A. fumigatus AUMC8872 -ve -ve -ve 17 ± 0.02 29 ± 0.1 40 ± 0.2 
A. niger AUMC8852 20 ± 0.03 -ve -ve 30 ± 0.4 30 ± 0.2 30 ± 0.007 
A. niger AUMC8856 20 ± 0.003 25 ± 0.1 35 ± 0.3 35 ± 0.02 43 ± 0.08 20 ± 0.1 
A. oryzae AUMC8863 30 ± 0.4 20 ± 0.02 -ve -ve 25 ± 0.04 -ve 
A. versicolor AUMC6872 33 ± 0.03 40  ± 0.1 30  ± 0.04 4± 0.001 37 ± 0.2 20 ± 0.01 
Circinella muscae AUMC8861 -ve -ve 30 ± 0.01 -ve -ve -ve 
Chaetomium globosum AUMC8862 -ve -ve 40 ± 0.3 25 ± 0.05 15 ± 0.4 -ve 
Fusarium 
F. lateritium AUMC6833 -ve -ve 5 ± 0.09 15 ± 0.01 20 ± 0.1 -ve 
F. oxysporum AUMC6827 -ve -ve -ve 5 ± 0.02 7.5 ± 0.05 -ve 
F. semitectum AUMC6816 -ve -ve -ve 10 ± 0.3 10 ± 0.01 -ve 
F. scirpi AUMC8858 -ve -ve -ve 15 ± 0.1 -ve -ve 
F. subglutinans AUMC 8839 -ve -ve 20 ± 0.08 -ve -ve -ve 
Gliocladium solani AUMC 6802 - ve -ve - ve -ve 5 ± 0.2 -ve 
Emericella 
E. nidulans AUMC 8854 28 ± 0.2 -ve 15 ± 0.04 -ve -ve 30 ± 0.02 
E. rugulosa AUMC8867 -ve -ve 20 ± 0.05 -ve -ve -ve 
Exophiala costellanii 
AUMC8865 -ve -ve -ve 15 ± 0.1 -ve -ve 
Papulaspora irregularis 
AUMC8843 -ve -ve -ve -ve -ve -ve 
Penicillium 
P. aurantiogriseum AUMC8847 -ve 30 ± 0.07 40 ± 0.2 15 ± 0.05 20 ± 0.1 15 ± 0.3 
P. funiculosum AUMC8850 28 ± 0.1 15 ± 0.01 14 ± 0.2 16 ± 0.08 40 ± 0.001 40 ± 0.05 
P. raistrickii AUMC7265 -ve 15 ± 0.04 15 ± 0.1 15 ± 0.06 18 ± 0.01 -ve 
Penicillium sp. AUMC8859 18 ± 0.1 -ve 20 ± 0.006 18 ± 0.01 14 ± 0.06 -ve 
Pleospora tarda AUMC 8871 -ve -ve -ve -ve 20 ± 0.03 -ve 
Standard (chloromphanicol) 5 ± 0.001 45 ± 0.06 40 ± 0.01 32 ± 0.1 30 ± 0.05 25 ± 0.08 
All results were recorded as mean values of three replicates ± standard deviation. 
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Table 2. Antifungal activities of the ethanolic extracts of 26 endophytic fungi against some strains of yeasts, 
dermatophytic and keratinophilic fungi 
 
Fungal strains 
 
Yeasts Dermatophytic fungi Keratinophilic fungi 
C. parapsilosis 
AUMC 9163 
C. albicans 
AUMC 
9212 
S. cerevisiae 
AUMC 203 
T. mentagrophytes 
AUMC 2360 
T. rubrum 
AUMC 
10337 
C. tropicum 
AUMC 1804 
Alternaria 
A. alternata AUMC 6836 -ve -ve -ve -ve -ve -ve 
A. alternata AUMC 8840 -ve -ve -ve 15 ± 0.1 -ve -ve 
A. alternata AUMC 8841 -ve -ve -ve -ve -ve -ve 
Aspergillus 
A. awamori AUMC 8855 -ve -ve -ve 30 ± 0.001 20 ± 0.3 20 ± 0.1 
A. fumigatus AUMC 8872 -ve -ve -ve 20 ± 0.005 35 ± 0.3 5 ± 0.03 
A. niger AUMC 8852 -ve -ve -ve 35 ± 0.02 30 ± 0.1 40 ± 0.09 
A. niger AUMC 8856 -ve -ve -ve 20 ± 0.1 15 ± 0.5 20 ± 0.01 
A. oryzae AUMC 8863 -ve -ve -ve 45 ± 0.07 35 ± 0.01 20 ± 0.3 
A. versicolor AUMC 6872 -ve -ve -ve 40 ± 0.03 -ve -ve 
Circinella muscae  
AUMC 8861 -ve -ve -ve -ve -ve -ve 
Chaetomium globosum 
AUMC 8862 -ve -ve -ve -ve -ve -ve 
Fusarium 
F. lateritium AUMC6833 -ve -ve -ve -ve -ve -ve 
F. oxysporumAUMC6827 -ve -ve -ve 40 ± 0.03 -ve -ve 
F. semitectum AUMC6816 -ve -ve -ve -ve -ve -ve 
F. scripi AUMC 8858 -ve -ve -ve 5 ± 0.03 -ve -ve 
F. subglutinans 
AUMC8839 -ve -ve -ve -ve -ve -ve 
Gliocladium solani  
AUMC 6802 -ve -ve -ve -ve -ve -ve 
Emericella 
E. nidulans AUMC 8854 -ve -ve -ve 30 ± 0.2 25 ± 0.06 2.5 ± 0. 3 
E. rugulosa AUMC 8867 -ve -ve -ve -ve 15 ± 0.1 -ve 
Exophiala costellanii 
AUMC 8865 -ve -ve -ve 20 ± 0.08 10 ± 0.04 -ve 
Papulaspora irregularis 
AUMC 8843 -ve -ve -ve -ve -ve -ve 
Penicillium 
P. aurantiogriseum 
AUMC 8847 -ve -ve -ve 35 ± 0.05 -ve 5 ± 0.2 
P. funiculosum A 
UMC 8850 -ve -ve -ve 45 ± 0.1 25 ± 0.4 30 ± 0.02 
P. restickii AUMC 7265 -ve -ve -ve -ve 20 ± 0.2 -ve 
Penicillium sp.  
AUMC 8859 -ve -ve -ve -ve 10 ± 0.03 -ve 
Pleospora tarda 
AUMC8871 -ve -ve -ve -ve -ve -ve 
Standard (clotrimazole) 35 ± 0. 30 25 ± 0.10 10 ± 0.03 30 ± 0.07 25 ± 0.20 15 ± 0.01 
All results were recorded as mean values of three replicates ± standard deviation 
 
 
 The extracts of 8 endophytic fungi (30.8% of 
tested strains) were affected on the two tested 
dermatophyte strains (Trichophyton mentagrophytes 
and T. rubrum) and gave inhibition zones ranged 
from 10-45 mm. Other 5 extracts were inhibited 
Trichophyton mentagrophytes only with inhibition 
zones ranged from 5-40 mm and other 3 fungal 
extracts were inhibited the growth of Trichophyton 
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rubrum with zones between 10-20 mm. Only 8 
fungal extracts have an inhibition activity against 
the keratinophilic fungus (Chrysosporium tropi-
cum). On the other hand, the extracts of all tested 
endophyte have no activities against any of the  
three tested yeast strains (Table 2). Seven endo-
phytic extracts show inhibition zones against all           
the three tested dermatophytic and keratinophilic 
strains. Penicillium funiculosum and Aspergillus 
oryzae show the highest inhibition zone (45 mm) 
against Tricophyton mentagrophytes, Aspergillus 
oryzae and Aspergillus fumigatus appeared their 
highest activities against Tricophyton rubrum with 
inhibition zone reached to 35 mm. Aspergillus niger 
formed the highest inhibition zone against Chryso-
sporium tropicum which reached to 40 mm (Table 2). 
 Recently, studies were done on the effect of 
endophytic extracts against both dermatophytes and 
yeasts. Tong et al. [35] examined methanolic and 
ethyl acetate extracts of 72 endophytic fungal 
isolates against yeast and fungi and recorded that 
only moderate antiyeast and antifungal activities 
were observed for both with diameter of inhibition 
zone less than 16 mm on disc diffusion assay. 
Seddek [40] found that about 50% of the crude 
ethanol and aqueous extracts of 57 endophytic 
fungal isolates on the growth of 6 human patho- 
genic fungi representing 3 species of Candida                 
(C. albicans, C. glabrata and C. krusei) and                      
3 dermatophytic fungi (Trichophyton rubrum,                
T. mentagrophytes and Epidermophyton floccosum) 
had no inhibition activities against all the 3 derma-
tophytic fungi while 72% of the extract affected            
the tested 3 species of Candida. Pharamat et al.            
[41] examined the antimicrobial activity of 73 
endophytic fungi against Saccharomyces cerevisiae 
and Candida albicans and found that 11 (15.1%)  
and 7 (9.6%) of isolates produced inhibition zones 
ranged from 9 to 30 mm against the 2 tested yeast 
species, respectively.  Kalyanasundaram et al. [37] 
reported that the crude extract of Aspergillus terreus 
inhibited Trichophyton rubrum, Candida albicans 
and Trichophyton mentagrophytes growth with 
inhibition zones reached to 8, 4 and 3 mm, respec-
tively. Also, the inhibitory effect of Clitocybe 
nebularis on Trichophyton mentagrophytes with 
inhibition zones of 9-11 mm [42]. Medicinal 
product from plants and mushrooms could be 
continually sourced and adequately utilized to treat 
dermatophyte infections [43, 44]. This antifungal 
activity may be attributed to the presence of 
glucanase [45] or ganoduric protein [46]. 
 
3.2. Anti-inflammatory activity 
 
In the present study, only 8 strains were 
selected for examined their anti-inflammatory 
activities (Table 3). The extracts of 3 of them 
(Aspergillus niger, Aspergillus awamori and 
Penicillium funiculosum) were recorded as effective 
on all Gram (+), Gram (-) bacteria and dermato-
phytic and keratinophilic fungi in the previous 
expriment. Other 3 extracts (Aspergillus fumigatus, 
Aspergillus oryzae and Emericella nidulans) 
appeared an inhibition effect on all dermato-    
phytic and keratinophilic fungi and some of 
bacterial strains under study. The 7 selected extract 
(Aspergillus versicolor) was recorded as inhibition 
for all bacterial strains and only one of derma-
tophyte. The last selected extract (Pleospora tarda) 
had no inhibitory activity against all tested bacterial 
and fungal strains with exception of Gram (+) 
Bacillus cereus. 
 As part of the investigation on the mechanism 
of the anti-inflammation activity, ability of the 
selected 8 fungal extracts to denaturated protein  
was studied (Table 3). All the fungal extracts and 
the standard were tested at 10 µl/ml concentra-    
tion. Emericella nidulans, Pleospora tarda, and 
Penicillium funiculosum extracts showed higher 
activities with inhibition % of protein denaturation 
reached to 83%, 82.5% and 81.4%, respectively. On 
the other hand, the extracts of all the 5 Aspergilli 
under study showed lower activities and inhibi-          
ted protein denaturation by 65-79.9% (Table 3). 
Standard diclofenac sodium recorded 77.4% 
inhibition of protein denaturation. Denaturation of 
proteins is well documented cause of inflammation 
and rheumatoid arthritis. Several anti-inflammatory 
drugs like salicylic acid have shown dose depen-
dent ability to inhibit thermally induced protein 
denaturation [47]. The inhibitory effect on bovine 
serum albumin denaturation by the ethanol extracts 
of the tested endophytes is shown in Table 3. 
Maximum inhibition was 95% was observed by 
ethanol Emericella nidulans extract at 50 µl/ml 
followed by Pleospora tarda (90.7% at the same 
concentration).  
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Table 3. Anti-inflammatory activity of ethanolic extracts of selected endophytic strains  
 
Fungal strains 
 
Protein 
denaturation 
Albumin 
denaturation 
HRBCs membrane 
stibilization 
% inhibition %  inhibition % inhibition 
Aspergillus awamorii AUMC 8855 77.9 % 53.9 % 62.8 % 
Aspergillus  fumigatus AUMC 8872 75 % 62.7 % 52.8 % 
Aspergillus niger AUMC 8856 71.7 % 82.4 % 59.3 % 
Aspergillus oryzae AUMC 8863 79.9 % 86 % 66.8 % 
Aspergillus versicolor AUMC 6872 65 % 69 % 63.4 % 
Emericella nidulans AUMC 8854 83 % 95 % 69.5 % 
Penicillium funiculosum AUMC 8850 81.4 % 57.7 % 52.7 % 
Pleospora tarda AUMC 8871 82.5 % 90.7 % 56.5 % 
Standard of diclofenac sodium 77.4 % 87.4 % 74.3 % 
All results were recorded as mean values of three replicates ± standard deviation 
 
 
 The standard anti-inflammatory drug, diclo-
fenac sodium showed 87.4% inhibition. The results 
recorded in this study are better than those recorded 
by Govindappa et al. [48] who found that methanol 
extract at 200 μg/ml concentration of Aspergillus 
niger showed 79% inhibition followed by Asper-
gillus alternata (78.6%) and Penicillium sp. 65.84%. 
 Since HRBCs membrane is similar to these 
lysosomal membrane components [49] and its 
stabilization implies that the extract may as well 
stabilize lysosomal membranes. So, the prevention 
of hypotonicity induced RBCs membrane lysis            
was taken as a measure in estimating the anti-
inflammatory property of the secondary metabolites 
of fungi. Thus, HRBCs membrane stabilization has 
been used as a method in estimating the anti-
inflammatory property [50, 51]. Stabilization of 
HRBCs membrane was studied for establishes the 
mechanism of anti-inflammatory action of ethanolic 
extracts of different 8 endophytes. All the tested 
extracts were effectively inhibiting the heat indu- 
ced hemolysis. These results provide evidence for 
membrane stabilization as a mechanism of their 
anti-inflammatory effect. This effect may possibly 
inhibit the release of lysosomal content of neutro-
phil at the site of inflammation. The extracts 
inhibited the heat induced hemolysis of HRBCs to 
varying degree (Table 3). The maximum inhibition 
was 69.5% by ethanolic extract of Emericella 
nidulans. The diclofenac standard drug recorded 
74.3% of inhibition. This result came in harmony 
with those recorded by Govindappa et al. [48] who 
showed that the maximum inhibition by methanol 
extract of  Aspergillus niger was 78.42% followed 
by Penicillium sp. (77.61%) and Aspergillus 
alternata (77.98%). Also they found that the aspirin 
standard drug showed 85.92%. Results of our 
findings confirmed the use of some endophytic 
fungi such as Emericella nidulans, Pleospora  
tarda, Aspergillus versicolor, Penicillium aurantio-
griseum, Penicillium funiculosum, Aspergillus 
awamori, Aspergillus niger, Aspergillus oryzae and 
Aspergillus fumigatus as sources of anti-microbial 
and/or anti-inflammatory drugs. This biological 
activity could be returned to the presence of 
phytochemicals like alkaloids, phenols, flavonoids, 
saponins, and terpenes in the endophytes [14]. The 
levels of phenolic and flavonoid compounds were 
correlated with the anti-inflammatory activity of the 
extracts [52]. The correlation between presence of 
flavonoids and their membrane stabilizing ability 
was approved by Sankari et al. [53]. Moreover, the 
main action of the anti-inflammatory agent is the 
inhibition of the cyclooxygenase system which is 
responsible for the biosynthesis of prostaglandins. 
NSAIDS like prostaglandins acts by inhibiting the 
lysosomal enzymes or by stabilizing the lysosomal 
membrane. Since RBCs membranes are similar                
to the lysosomal membrane components, the 
prevention of hypotonicity-induced HRBCs lysis 
was taken as measure of anti-inflammatory activity 
of drugs. The indomethacin drugs as inhibitor of 
prostaglandins biosynthesis act either by inhibiting 
these lysosomal enzymes or by stabilizing the 
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lysosomal membrane [54, 55]. Thus secondary 
metabolites of endophytic fungi have a promising 
potential to be included in antimicrobial and anti-
inflammatory drug discovery program.  
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